Skip to main content
. 2021 Dec 7;37(2):340–349. doi: 10.3904/kjim.2021.088

Figure 3.

Figure 3

Overall survival for bridge to transplantation (BTT) and destination therapy (DT) patients stratified by implanted device. In both (A) BTT/bridge to candidacy (BTC) and (B) DT patients, survivals were similar between devices. HMII, HeartMate II; HVAD, HeartWare Ventricular Assist Device.